Development of matrix type transdermal patches of lercanidipine hydrochloride: Physicochemical and in-vitro characterization

Daru

Volumn 18, Issue 1, 2010, Pages 9-16

  Mamatha, T ^a   Venkateswara Rao, J ^a   Mukkanti, K ^b   Ramesh, G ^c  

^a SULTAN UL ULOOM COLLEGE OF PHARMACY   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c KAKATIYA UNIVERSITY   (India)

Author keywords

d limonene; Eudragit RL 100; Hydroxypropyl methyl cellulose; Lercanidipine hydrochloride; Transdermal patch

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; LERCANIDIPINE; LIMONENE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EX VIVO STUDY; IN VITRO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SKIN IRRITATION; TRANSDERMAL PATCH; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 77949768150     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Chien YW. Novel Drug Delivery Systems. NewYork, Marcel Dekker. 1992; 301.
2. Petkar KC, Kuchekar BS. In-vitro percutaneous absorption of losartan potassium in human skin and prediction of human skin permeability. DARU 2007; 15(2): 53-60.
3. Williams AC, Barry BW. In: Scott RC, Guy RH, Hadgraft J. (Eds.) Prediction of Percutaneous Penetration. London, IBC Technical Services. 1990; 2: 224-230.
4. Krishnaiah YSR, Satyanarayana V, Bhaskar P. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm 2002; 247: 91-102.
5. Dnyanesh NT, Vavia PR. Acrylate-based transdermal therapeutic system of nitrendipine. Drug Dev Ind Pharm 2003; 29, 1: 71-78.
6. Ramesh G, Vamshi Vishnu Y, Kishan V, Madhusudan Rao Y. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties. PDA J Pharm Sci Technol 2008; 62(6): 391-401.
7. Bang ML, Chapman MT, Goa LK. Lercanidipine a review of its efficacy in the management of hypertension. Drugs 2003; 63: 449-2472.
8. Barchielli M, Dolfini E, Farina P. Clinical pharmacokinetics of lercanidipine. J Cardiovasc Pharmacol 1997; 29: S1-S15.
9. Kaidi Z, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Rel 1999; 62: 359-366.
10. Hayton WL, Chen T. Correction of perfusate concentration for sample removal. J Pharm Sci 1982; 71: 820-821.
11. Barry BW. Penetration enhancers: Dermatological formulations. New York, Marcel Dekker. 1983; 160-172.
12. Williams AC, Barry BW. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm Res 1991; 8: 17-24.
13. Devi K, Saisivum S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 2003; 5: 495-503.
14. Arora P, Mukherjee B. Design, development, physicochemical and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci 2002; 91: 2076-2089.
15. Gupta R, Mukherjee B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethyl cellulose matrices. Drug Dev Ind Pharm 2003; 29: 1-7.
16. Draize JH, Woodword G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944; 82: 377-379.
17. Rhee Y 17. S, Choi JG, Park ES, Chi SC. Transdermal delivery of ketoprofen using microemulsions. Int J Pharm 2001; 228(1-2): 161-70.
18. Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm 2008; 34(6): 618-26.
19. Krishnaiah YSR, Satyanarayana V, Bhaskar P. Effect of limonene on the in vitro permeation of nicardipine hydrochloride across the excised rat abdominal skin. Pharmazie 2002; 57: 842-847.
20. Moghimi HR, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm 1997; 146: 41-54.
21. Mutalic S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci 2004; 93: 1577-1594.
22. Costa P, Lobo SJM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123-133.
23. Rao PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Phar 1998; 24: 327-336.